|
|



How Low Can You Go . . . Safely?
Stephen D. Wiviott, MD The benefits of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been observed in major primary2-4 and secondary3-7 prevention trials across a wide range of cholesterol levels in stable patients.
|

|
|